IMDS

IMDS (Interventional Medical Device Solutions) is a medical technology company based in the Netherlands. The company focuses on improving patient outcomes in percutaneous coronary interventions (PCI), which are minimally invasive procedures for treating coronary artery disease. IMDS develops advanced product solutions using innovative in-house technology, particularly for complex procedures like CHIP (Complex High-risk Indicated Procedures) and CTO (Chronic Total Occlusion) interventions. With its own manufacturing facility in Roden, Drenthe, IMDS ensures comprehensive quality control from product concept to final production. This vertical integration allows the company to deliver high-quality medical devices tailored for interventional cardiology. IMDS serves interventional cardiologists, healthcare providers, and hospitals involved in PCI procedures, contributing to advancements in cardiovascular treatment. The company employs around 98 people and generates annual revenues of approximately $12.6 million.

• Employees 84